Essure® hydrosalpinx occlusion prior to IVF-ET as an alternative to laparoscopic salpingectomy

Velja Mijatovic; Kim Dreyer; Emanuel MH; Mark Hans Emanuel; Roel Schats; R. Schats; Schats R; Peter G A Hompes; Hompes PG

doi:10.1016/j.ejogrb.2011.12.001

Essure® hydrosalpinx occlusion prior to IVF-ET as an alternative to laparoscopic salpingectomy

Velja Mijatovic, Kim Dreyer, Emanuel MH, Mark Hans Emanuel, Roel Schats, R. Schats, Schats R, Peter G A Hompes, Hompes PG

European journal of obstetrics, gynecology, and reproductive biology · 2011 · vol. 161(1) , pp. 42–45 · doi:10.1016/j.ejogrb.2011.12.001 · PMID:22200254 · W2154636986

article OA: closed CC0 ⤵ 3 in-corpus citations

View on OpenAlex View on PubMed View at publisher

⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study investigated Essure® placement as an alternative to laparoscopic salpingectomy for treating hydrosalpinx prior to IVF-ET.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveTo investigate the success rate of proximal tubal occlusion with Essure(®) devices in subfertile women with unilateral or bilateral hydrosalpinx and to observe the results of subsequent treatment with IVF-ET and/or frozen embryo transfer.Study designProspective, single-arm, clinical study in 20 women with unilateral or bilateral hydrosalpinges (all visible on transvaginal ultrasound) due to undergo IVF-ET and/or frozen embryo transfer. In all patients, laparoscopy was considered to be contraindicated due to extensive pelvic adhesions.Result(s)In all patients the Essure(®) devices were placed in an ambulant setting without any complications. Proximal tubal occlusion was confirmed by hysterosalpingography in 19 out of 20 patients (95%) and in 26 of 27 treated tubes (96%). After 45 embryo transfer procedures in 19 patients, 18 pregnancies with 12 live births, 6 miscarriages and 1 immature delivery (probably related to cervical insufficiency leading to chorioamnionitis and subsequent rupture of the membranes) were observed.Conclusion(s)Essure(®) devices are effective in inducing proximal tubal occlusion in subfertile patients with hydrosalpinges. After artificial reproductive treatments a cumulative live birth rate per patient of 63% and a cumulative live birth rate per transfer of 27% were achieved. The latter was related to the large proportion of patients with severe endometriosis.

My notes (saved in your browser only)

MeSH descriptors

Sterilization, Tubal Adult Contraindications Embryo Transfer Female Fertilization in Vitro Fertilization in Vitro Humans Laparoscopy Pregnancy Salpingectomy Sterilization, Tubal Sterilization, Tubal

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

Effect of endometriosis on in vitro fertilization 2002

Cited by (3)

References (15)

Effect of endometriosis on in vitro fertilization via openalex
doi:10.1002/14651858.cd002125.pub3 via openalex
doi:10.1093/oxfordjournals.humrep.a019053 via openalex
doi:10.1016/j.fertnstert.2006.07.1549 via openalex
doi:10.1016/j.jmig.2011.01.016 via openalex
doi:10.1093/humupd/6.4.387 via openalex
doi:10.1093/humrep/14.5.1243 via openalex
doi:10.1016/j.fertnstert.2007.07.071 via openalex
doi:10.1016/j.fertnstert.2004.05.034 via openalex
doi:10.1093/humrep/13.6.1696 via openalex
doi:10.1016/j.fertnstert.2008.11.022 via openalex
doi:10.1093/humrep/16.11.2403 via openalex
doi:10.1016/s0015-0282(98)00200-3 via openalex
doi:10.1016/j.fertnstert.2004.10.056 via openalex
doi:10.1016/j.fertnstert.2007.01.050 via openalex

Cited by (3)

Source provenance

europepmc: last seen: 2026-07-31T06:09:14.520117+00:00
openalex: last seen: 2026-05-11T06:00:05.006021+00:00
pubmed: last seen: 2026-05-13T22:16:23.388809+00:00

License: CC0 · commercial use OK

[1] Effect of endometriosis on in vitro fertilization 2002